Skip to main content

NATIXIS ADVISORS, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1018331 Boston, MA

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$97,099,986
+$2,477,987 QoQ
Shares Held
125,673
+2.5% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21.485919807755046.ToString("F0")% Shared 0.ToString("F0")% None 78.51408019224495.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $475,548,112 across 32 Biotechnology names. REGN ranks #2 (20.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
125,673 $97,099,986

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $97,099,986 125,673
2025-12-31 $94,621,999 122,588
2025-09-30 $67,533,686 120,109
2025-06-30 $59,338,125 113,025
2025-03-31 $73,717,820 116,232
2024-12-31 $78,312,135 109,938
2024-09-30 $122,997,181 117,002
2024-06-30 $122,637,333 116,683
2024-03-31 $109,688,247 113,963
2023-12-31 $96,978,146 110,417
2023-09-30 $91,365,841 111,021
2023-06-30 $79,861,408 111,144
2023-03-31 $92,029,504 112,003
2022-12-31 $77,498,847 107,415
2022-09-30 $92,905,140 134,866
2022-06-30 $79,916,046 135,192
2022-03-31 $122,847,188 175,893
2021-12-31 $114,488,891 181,291
2021-09-30 $153,020,972 252,852
2021-06-30 $76,593,706 137,132
2021-03-31 $65,453,239 138,338
2020-12-31 $69,284,253 143,413
2020-09-30 $104,419,121 186,536
2020-06-30 $121,304,913 194,508
2020-03-31 $102,196,166 209,294